Haiping Tang

Title: Haiping Tang: Innovator in HPV Vaccine Development

Introduction

Haiping Tang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines against human papillomavirus (HPV). His innovative work focuses on identifying linear B-cell epitopes that can be utilized in vaccine formulations.

Latest Patents

Haiping Tang holds a patent titled "Minimal motifs of linear B-cell epitopes in L1 protein from human papillomavirus type 58 and their applications." This patent discloses eighteen linear epitope motifs and their extended 8-mer peptides in the L1 protein from HPV 58. These motifs can be used as antigens to specifically detect serum from subjects infected with HPV 58. Additionally, they can aid in the development of preventive or therapeutic multi-epitope peptide vaccines against HPV 58 by inducing humoral immunity. Among the eighteen B-cell epitope motifs, ten are 100% conservative, while one is highly conservative among many homologous proteins of high-risk HPVs. These motifs serve as candidate 'universal' epitopes for vaccine development.

Career Highlights

Haiping Tang is associated with Hengsun Pharmaceutical Technology Co. Ltd., where he continues to advance research in vaccine technology. His work has the potential to significantly impact public health by providing effective solutions against HPV infections.

Collaborations

He collaborates with notable colleagues such as Wanxiang Xu and Shaohua Gu, contributing to a dynamic research environment focused on innovative healthcare solutions.

Conclusion

Haiping Tang's contributions to HPV vaccine development highlight his role as a key innovator in the field of biotechnology. His work not only advances scientific knowledge but also holds promise for improving health outcomes related to HPV infections.